Enhanced axillary assessment using contrast enhanced ultrasound (CEUS) before neo-adjuvant systemic therapy (NACT) in breast cancer patients identifies axillary disease missed by conventional B-mode ultrasound that may be clinically relevant

Background: Accurate axillary assessment prior to NACT is important for treatment planning. De-escalation of axillary surgery after NACT in patients with pre-treatment lymph node (LN) metastases is becoming more widespread but there are concerns about patient selection. CEUS can be used to augment conventional B-mode ultrasound and improve metastatic LN detection.

Source: European Journal of Cancer - September 30, 2020 Category: Cancer & Oncology Authors: K. Cox, N. Dineen, J. Weeks, D. Allen, D. Akolekar, R. Chalmers, R. Burcombe, C. Harper-Wynne, R. Jyothirmayi, C. Abson Tags: POSTERS A: Optimal Diagnosis Source Type: research